Ranjitha Gaddipati

机构：AstraZeneca (Poland), AstraZeneca (Finland), AstraZeneca (United States)

发表论文 8 篇 · 总被引 76 次 · h-index 4

代表论文

• LOX-1: A potential driver of cardiovascular risk in SLE patients (2020 · PLoS ONE · 被引 29)
• Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis (2019 · JAMA Dermatology · 被引 27)
• High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity (2023 · Journal of the American Heart Association · 被引 15)
• Relationship of Soluble Lectin‐Like Low‐Density Lipoprotein Receptor‐1 (sLOX‐1) With Inflammation and Coronary Plaque Progression in Psoriasis (2023 · Journal of the American Heart Association · 被引 4)
• Soluble LOX-1: A Potential biomarker for SLE and Cardiovascular Comorbidity (2018 · The Journal of Immunology · 被引 1)
• Structural and functional studies of a monoclonal antibody blocking LOX-1 (2023 · Figshare)